-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
<>.
CRC is one of the most common malignant tumors of the digestive tract
Abnormal cell metabolism is closely related to the occurrence and development of tumors, and uncontrolled metabolism has become an important feature of cancer
Yang Weiwei's group research found that the monoubiquitination modification of PHGDH, a key enzyme in the serine synthesis pathway, promotes the transfer of CRC
By analyzing a large number of samples of CRC patients, they found that compared with CRC in situ tumor tissue, the content of SAM in liver metastasis tumor tissue was higher; compared with CRC patients without metastasis and recurrence, CRC patients with metastasis and recurrence contained serum The content of SAM is higher
This work discovered a new function of serine metabolism regulation to promote CRC metastasis; revealed a new mechanism for monoubiquitination to regulate PHGDH activity and SAM production to promote CRC metastasis; it suggested that blocking the serine synthesis pathway can inhibit liver metastasis of CRC and tumor tissues And the content of SAM in serum can predict the metastasis and prognosis of CRC
Researcher Yang Weiwei from the Center of Excellence for Molecular Cells, Professor David Li, Professor Li Xinxiang from Fudan University Cancer Hospital, and Professor Wang Xiongjun from Guangzhou University are the co-corresponding authors of the paper
Article link: https://
The monoubiquitination modification of PHGDH promotes liver metastasis of colorectal cancer